In the past few decades the sector has gone from living outside the traditional health care system, viewed almost as a luxury good, to a serious industry garnering serious money. Piper Sandler research puts the U.S. fertility market at $15.4 billion by 2023, up from almost $7 billion in 2017. Millennials, now the primary demographic having babies, are aging into fertility treatment and are set to reshape the space in the same ways they’ve transformed so many other parts of our economy. Investors have taken notice, funneling $646 million into the sector in 2018, according to PitchBook. “Real dollars are starting to flow into this category,” says Stephanie Palmeri, a partner with VC firm Uncork Capital. The past few years have seen the launch of businesses encompassing everything from simple ovulation trackers to research plays attempting to discover links between genetics and reproductive disorders. Private equity firms, drawn to the industry’s high margins and increased success rates, are rolling up fragmented mom-and-pop fertility clinics.
Read the full article: Fertility Inc.: Inside the Big Business of Babymaking //